Author:
Herold M.,Boeser V.,Russe E.,Klotz W.
Subject
General Medicine,Immunology,Immunology and Allergy
Reference45 articles.
1. Aho, K, Palosuo, T, Lukka, M, Kurki, P, Isomaki, H, Kautiainen, H, von Essen, R. Anti-filaggrin antibodies in recent-onset arthritis Scand J Rheumatol, 1999; 28: 113–116
2. Araki, C, Hayashi, N, Moriyama, M, Morinobu, S, Mukai, M, Koshiba, M, Kawano, S, Kumagai, S. Usefulness of anti-cyclic citrullinated peptide antibodies (anti-CCP) for the diagnosis of rheumatoid arthritis Rinsho Byori, 2004; 52: 966–972
3. Arnett, FC, Edworthy, SM, Bloch, DA, McShane, DJ, Fries, JF, Cooper, NS, Healey, LA, Kaplan, SR, Liang, MH, Luthra, HS. The American Rheumatism Association 1987 revised Criteria for the classification of rheumatoid arthritis Arthritis Rheum, 1988; 31: 315–324 et al.
4. Bas, S, Perneger, TV, Seitz, M, Tiercy, JM, Roux-Lombard, P, Guerne, PA. Diagnostic tests for rheumatoid arthritis: Comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors Rheumatology, 2002; 41: 809–814
5. Bas, S, Genevay, S, Meyer, O, Gabay, C. Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis Rheumatology, 2003; 42: 677–680
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献